Erschienen in:
01.03.2005 | Poster presentation
Can high efficiency aerosol delivery continue after extubation?
verfasst von:
J Fink, P Dunne, R MacLoughlin, G O'Sullivan
Erschienen in:
Critical Care
|
Sonderheft 1/2005
Einloggen, um Zugang zu erhalten
Excerpt
Aerogen is currently developing drug/device combinations for delivery of drug to the lungs of mechanically ventilated patients with efficiencies above 60%. When therapy needs to continue post extubation, an aerosol delivery device of similar efficiency is required to deliver the same drug dose. Commercially available nebulizers with inhaled mass ranging from 6 to 30% would require several doses to achieve the same inhaled mass. We modified the pulmonary drug delivery system (PDDS; Aerogen) to provide similar drug delivery efficiencies to patients on and off the ventilator. …